Distinguished Speakers (confirmed)
Jay A. Nelson, Ph.D.
Founder and Chief Executive Officer
Vaccine and Gene Therapy Institute at Oregon Health & Sciences University
Richard Jove, Ph.D.
Director, Vaccine & Gene Therapy Institute of Florida
Mel Rothberg, B.E., M.B.A.
Chief Operating Officer, Vaccine & Gene Therapy Institute of Florida
Alan Aderem, Ph.D. - Seattle BioMed
Mark Cameron, Ph.D. - VGTI Florida
Sumit Chanda, Ph. D. - La Jolla Institute of Allergy and Immunology
Nicolas Chomont, Ph.D. - VGTI Florida
Steve Deeks, M.D. - University of California San Francisco
Annie De Groot, M.D. - University of Rhode Island
Michael Diamond, M.D., Ph.D. - Washington University St. Louis
Michael Farzan, Ph.D. - Scripps Florida
Thomas Gajewski, M.D., Ph.D. - University of Chicago
Elias Haddad, Ph.D. - VGTI Florida
John Hiscott, Ph.D. - VGTI Florida
Keith Knutson, Ph.D. - VGTI Florida
Michael Lederman, M.D. - Case Western Reserve University
Grant McFadden, Ph.D. - University of Florida
Shannon McWeeney, Ph.D. - Oregon Health and Science University
Santosh Mishra, Ph.D. - VGTI Florida
Susan Moir, Ph.D. - National Institute of Allergy and Infectious Disease
Janko Nikolich-Žugich, M.D., Ph.D. - University of Arizona
Ted Ross, Ph.D. - VGTI Florida
Michel Sadelain, M.D., Ph.D. - Memorial Sloan-Kettering Cancer Center
John Schatzle, Ph.D. - VGTI Florida
Rafick-Pierre Sékaly, Ph.D. - VGTI Florida
Mario Stevenson, Ph.D. - University of Miami
Lydie Trautmann, Ph.D. - VGTI Florida
David Watkins, Ph.D. - University of Miami
It is a great honor for VGTI Florida to host this conference, and, as reflected in our plenary speaker program, we have organized an outstanding series of lectures by leading scientists and clinicians from North America at a great time of the year in Florida. Come join us and learn the latest breakthroughs from world-class scientists!
This exciting program and updates will be posted on the conference website as they become available.